Circulating microRNA as a biomarker of human growth hormone administration to patients

Drug Testing and Analysis

Volumn 6, Issue 3, 2014, Pages 234-238

  Kelly, Brian N ^a   Haverstick, Doris M ^a   Lee, Jae K ^a   Thorner, Michael O ^a   Vance, Mary Lee ^a   Xin, Wenjun ^a   Bruns, David E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Acromegaly; Circulating nucleic acids; Doping; Growth hormone; MicroRNA; Performance enhancement; Sports

Indexed keywords

DIAGNOSIS; POLYMERASE CHAIN REACTION; RNA; SPORTS;

'CURRENT; ACROMEGALY; CIRCULATING MICRORNA; CIRCULATING NUCLEIC ACID; GROWTH HORMONES; HUMAN GROWTH HORMONE; MICRORNA; PERFORMANCE ENHANCEMENTS; PHARMACEUTICAL AGENTS; SHORT TIME FRAMES;

BIOMARKERS;

BIOLOGICAL MARKER; HUMAN GROWTH HORMONE; MICRORNA;

ARTICLE; ATHLETE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPETITION; CONTROLLED STUDY; DOPING; HUMAN; HYPOTHESIS; IMMUNOASSAY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST;

ACROMEGALY; CIRCULATING NUCLEIC ACIDS; DOPING; GROWTH HORMONE; MICRORNA; PERFORMANCE ENHANCEMENT; SPORTS;

DOPING IN SPORTS; HUMAN GROWTH HORMONE; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SUBSTANCE ABUSE DETECTION;

EID: 84896404583     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1469     Document Type: Article

References (20)

1. D. P. Bartel. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281.
2. L. He, G. J. Hannon. MicroRNAs: Small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5, 522.
3. J. A. Weber, D. H. Baxter, S. Zhang, D. Y. Huang, K. How Huang, M. Jen Lee, D. J. Galas, K. Wang. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56, 1733.
4. T. Zenz, J. Mohr, E. Eldering, A. P. Kater, A. Bühler, D. Kienle, D. Winkler, J. Durig, M. H. J. van Oers, D. Mertens, H. Dohner, S. Stilgenbauer. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009, 113, 3801.
5. M. Thevis, S. Guddat, U. Flenker, W. Schanzer, Quantitative analysis of urinary glycerol levels for doping control purposes using gas chromatography-mass spectrometry. Eur. J. Mass Spectrom. 2008, 14, 117.
6. A. L. Baggish, A. Hale, R. B. Weiner, G. D. Lewis, D. Systrom, F. Wang, T. J. Wang, S. Y. Chan. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J. Physiol. 2011, 589, 3983.
7. N. Pfaff, T. Moritz, T. Thum, T. Cantz. miRNAs involved in the generation, maintenance, and differentiation of pluripotent cells. J. Mol. Med. 2012, 90, 747.
8. A. M. Cheng, M. W. Byrom, J. Shelton, L. P. Ford. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33, 1290.
9. Y. Zhang, D. Liu, X. Chen, J. Li, L. Li, Z. Bian, F. Sun, J. Lu, Y. Yin, X. Cai, Q. Sun, K. Wang, Y. Ba, Q. Wang, D. Wang, J. Yang, P. Liu, T. Xu, Q. Yan, J. Zhang, K. Zen, C. Y. Zhang. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39, 133.
10. M. A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A. K. Sood, G. A. Calin. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 2011, 8, 467.
11. N. Leuenberger, N. Jan, S. Pradervand, N. Robinson, M. Saugy. Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse. Drug Test. Anal. 2011, 3, 771.
12. Z. G. Mao, D. S. He, J. Zhou, B. Yao, W. W. Xiao, C. H. Chen, Y. H. Zhu, H. J. Wang. Differential expression of microRNAs in GH-secreting pituitary adenomas. Diagn. Pathol. 2010, 5, 79.
13. N. Jain, J. Thatte, T. Braciale, K. Ley, M. O'Connell, J. K. Lee. Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 2003, 19, 1945.
14. G. K. Smyth. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. DOI: 10.2202/1544-6115.1027.
15. R. Core. R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2012.
16. P. E. Sottas, N. Robinson, O. Rabin, M. Saugy. The athlete biological passport. Clin. Chem. 2011, 57, 969.
17. P. A. Kumar, K. Kotlyarevska, P. Dejkhmaron, G. R. Reddy, C. Lu, M. S. Bhojani, R. K. Menon. Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox2 (ZEB2) in the glomerular podocyte: A novel action of gh with implications for the pathogenesis of diabetic nephropathy. J. Biol. Chem. 2010, 285, 31148.
18. X. Wang. miRDB: A microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14, 1012.
19. M. Bidlingmaier, J. Suhr, A. Ernst, Z. Wu, A. Keller, C. J. Strasburger, C. J. Bergmann. High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin. Chem. 2009, 55, 445.
20. I. Erotokritou-Mulligan, E. Eryl Bassett, D. A. Cowan, C. Bartlett, P. Milward, A. Sartorio, P. H. Sonksen, R. I. Holt. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score. Clin. Endocrinol. 2010, 72, 520.